Table 1.
Summary of clinical features, WHO grades, and genetic statuses.
| Case | Age | Sex | Location | Diagnosis | WHO Grade | Genetic Status | EOR | OS (months) | Dead/Alive |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 29 | M | M-C5 | Pilocytic astrocytoma | 1 | - | 50% | 66 | A |
| 2 | 19 | M | Th8-12 | Pilocytic astrocytoma | 1 | - | 90% | 34 | A |
| 3 | 48 | F | M-C4 | Pilocytic astrocytoma | 1 | - | 30% | 62 | A |
| 4 | 53 | F | M-C5 | Astrocytoma | 2 | IDH-mut | 40% | 22 | A |
| 5 | 42 | F | C5-Th3 | Astrocytoma | 2 | IDH-mut | 60% | 37 | A |
| 6 | 14 | M | M-C6 | Glioblastoma | 4 | H3F3A-mut | 5% | 18 | D |
| 7 | 62 | F | Th10-12 | Anaplastic astrocytoma | 3 | H3F3A-mut | 30% | 22 | D |
| 8 | 15 | M | M-C1 | Anaplastic astrocytoma | 3 | H3F3A-mut | 60% | 57 | D |
M, male; F, female; M, medulla oblongata; C, cervical spine; Th, thoracic spine; mut, mutant; EOR, extent of resection; OS, overall survival time from diagnosis.